New Bone Therapeutics Phase II Trial of ALLOB for Severe Osteoporosis
Bone Therapeutics is planning a Phase II trial with ALLOB® allogeneic bone cell therapy for the treatment of severe osteoporosis. ...
May 19, 2016,
New Bone Therapeutics Phase II Trial of ALLOB for Severe Osteoporosis
Bone Solutions Receives $1.7MM in Funding
Bone Solutions closed a funding round for a total of >US $1.7MM, and affirmed an additional $1.65MM commitment from Next...
May 19, 2016,
Anika Therapeutics Launches CINGAL in Canada
Anika Therapeutics announced Canada launch of CINGAL® viscosupplement, cleared to treat knee osteoarthritis pain. CINGAL will be marketed by Pendopharm....
May 19, 2016,
The Pursuit of Infection Prevention: Curbing Readmissions and Costs
Post-surgical infection control is a priority in the reduction of complications, revisions and costs. It's a topic of importance along...
May 19, 2016,
Johnson & Johnson Collaborating with HP on 3D Printing Technologies
Johnson & Johnson is collaborating with a subsidiary of HP on use of 3D printing technologies to develop patient-customized products...
May 18, 2016,
Mazor Robotics Signs Commercial and Investment Agreements With Medtronic
Mazor Robotics entered into strategic agreements with Medtronic for equity investment and for co-development/potential global distribution of certain Mazor products. ...
May 18, 2016,
Novastep and Vivex Biomedical to Launch bioSTART Biologics
Novastep signed an agreement with Vivex Biomedical to launch bioSTART® Tissue Repair products, offering amniotic membranes and liquid to support foot and...
May 17, 2016,
Further Results from Bone Therapeutics ALLOB Phase I/IIA Delayed-Union Fracture Trial
Bone Therapeutics announced positive efficacy results for the 2nd patient cohort in its Phase I/IIA trial of ALLOB® allogeneic bone cell therapy product for the...
May 17, 2016,
Zimmer Biomet Completes Acquisition of Cayenne Medical
Zimmer Biomet closed its previously-announced acquisition of Cayenne Medical, a manufacturer of soft tissue repair and reconstruction products for the...
May 16, 2016,
Orthofix Announces FDA Clearance, Limited Launch of FORZA PTC Interbody Spacer
Orthofix announced FDA 510(k) clearance and U.S. limited launch of the FORZA® PTC™ (Peek Titanium Composite) Spacer....
May 16, 2016,
Loading new posts...
No more posts
